国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產品名稱 貨號 規格
Recombinant Vibrio cholerae serotype O1 Cell division protein FtsQ (ftsQ), partial CSB-YP888586VEX
CSB-EP888586VEX
CSB-BP888586VEX
CSB-MP888586VEX
CSB-EP888586VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase (dapD) CSB-YP888587VEX
CSB-EP888587VEX
CSB-BP888587VEX
CSB-MP888587VEX
CSB-EP888587VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Na (+)-translocating NADH-quinone reductase subunit A (nqrA) CSB-YP888588VEX
CSB-EP888588VEX
CSB-BP888588VEX
CSB-MP888588VEX
CSB-EP888588VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 6,7-dimethyl-8-ribityllumazine synthase (ribH) CSB-YP888589VEX
CSB-EP888589VEX
CSB-BP888589VEX
CSB-MP888589VEX
CSB-EP888589VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 1-deoxy-D-xylulose 5-phosphate reductoisomerase (dxr) CSB-YP888590VEX
CSB-EP888590VEX
CSB-BP888590VEX
CSB-MP888590VEX
CSB-EP888590VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Flagellar P-ring protein (flgI) CSB-YP888591VEX
CSB-EP888591VEX
CSB-BP888591VEX
CSB-MP888591VEX
CSB-EP888591VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (ispE) CSB-YP888592VEX
CSB-EP888592VEX
CSB-BP888592VEX
CSB-MP888592VEX
CSB-EP888592VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Succinyl-diaminopimelate desuccinylase (dapE) CSB-YP888593VEX
CSB-EP888593VEX
CSB-BP888593VEX
CSB-MP888593VEX
CSB-EP888593VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 tRNA 5-methylaminomethyl-2-thiouridine biosynthesis bifunctional protein MnmC (mnmC), partial CSB-YP888594VEX
CSB-EP888594VEX
CSB-BP888594VEX
CSB-MP888594VEX
CSB-EP888594VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 UPF0135 protein VC_2093 (VC_2093) CSB-YP888595VEX
CSB-EP888595VEX
CSB-BP888595VEX
CSB-MP888595VEX
CSB-EP888595VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Ribosomal large subunit pseudouridine synthase C (rluC) CSB-YP888596VEX
CSB-EP888596VEX
CSB-BP888596VEX
CSB-MP888596VEX
CSB-EP888596VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 50S ribosomal protein L32 (rpmF) CSB-YP888597VEX
CSB-EP888597VEX
CSB-BP888597VEX
CSB-MP888597VEX
CSB-EP888597VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase (menD), partial CSB-YP888598VEX
CSB-EP888598VEX
CSB-BP888598VEX
CSB-MP888598VEX
CSB-EP888598VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 ATP-dependent Clp protease proteolytic subunit (clpP) CSB-YP888599VEX
CSB-EP888599VEX
CSB-BP888599VEX
CSB-MP888599VEX
CSB-EP888599VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Lipid A export ATP-binding/permease protein MsbA (msbA), partial CSB-YP888600VEX1
CSB-EP888600VEX1
CSB-BP888600VEX1
CSB-MP888600VEX1
CSB-EP888600VEX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Crossover junction endodeoxyribonuclease RuvC (ruvC) CSB-YP888601VEX
CSB-EP888601VEX
CSB-BP888601VEX
CSB-MP888601VEX
CSB-EP888601VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 N-acetylmannosamine kinase (nanK) CSB-YP888602VEX
CSB-EP888602VEX
CSB-BP888602VEX
CSB-MP888602VEX
CSB-EP888602VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Glucose-1-phosphate adenylyltransferase 1 (glgC1) CSB-YP888603VEX
CSB-EP888603VEX
CSB-BP888603VEX
CSB-MP888603VEX
CSB-EP888603VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 UPF0313 protein VC_1711 (VC_1711), partial CSB-YP888604VEX
CSB-EP888604VEX
CSB-BP888604VEX
CSB-MP888604VEX
CSB-EP888604VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Ribosomal small subunit pseudouridine synthase A (rsuA) CSB-YP888605VEX
CSB-EP888605VEX
CSB-BP888605VEX
CSB-MP888605VEX
CSB-EP888605VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質形式,可以通過多種方式產生大量蛋白質、修改基因序列和制造有用的商業產品。重組蛋白的技術資源在重組蛋白的開發過程中,除了表達系統之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質量的重組蛋白,后續的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據他們開發重組蛋白的經驗總結出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產,在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質合成機制來產生由該基因編碼的蛋白質。表達載體可使外源基因在宿主細胞中高效表達,經過多年的發展,表達載體已成為一種成熟而受歡迎的生物技術。在重組蛋白生產過程中是一種基本成分。正如標題所示,本文主要總結了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質?

根據重組蛋白的不同應用,對其生物活性有不同的要求。但是我們如何確保蛋白質的產生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質有任何疑問,涉及到蛋白質的價格、交貨、質量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>